Our laboratory studies human stem cells and their potential application for therapeutic purposes. We aim to establish new efficient protocols for derivation of novel human embryonic stem cell lines. Furthermore, we seek to generate new disease models based on mutation-carrying human embryonic stem cell lines which can be used to study diseases and develop new therapies. Finally, we are investigating whether stem cells from human cord blood can be reprogrammed to serve as the equivalent of embryonic stem cells.